Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Pfizer Stock Bolted Higher in July

TheMotleyFool

0 0

Mega-cap pharma stocks rarely surge by double digits over just a 30-day period. But that's exactly what Pfizer's (NYSE: PFE) stock accomplished during the month of July.

Despite facing falling sales for a host of former blockbuster medicines and the impending spin-off of its legacy products unit, Pfizer's shares gained an astounding 17.7% in value last month, according to data provided by S&P Global Market Intelligence. The pharma giant thus tacked on a remarkable $33 billion to its market cap last month.

Image source: Getty Images.

Source Fool.com

Like: 0

PFE

Share